liraglutide in prediabetes

liraglutide is not approved in the US for prediabetes, and has 10 trials on file here in this condition. 7 of them are phase 3 or later. No trial here has a completion date still in the future, so this is a closed body of work rather than an active programme. Being studied in a condition is not the same as being approved for it; most such programmes end without an approval.

10 registered trials study liraglutide (Saxenda, Victoza, Xultophy) in prediabetes. None has a scheduled reporting date on file.

Trials on file: 10
Active: 0
Active phase 3: 0
Participants in active trials: 0
Sponsors: 9
Scheduled readouts: 0

All trials on file

Every registered trial of liraglutide grouped under prediabetes, largest first. Grouping follows the registry’s own condition wording.

Trial	Status	Phase	Sponsor
Improving Beta Cell Function in Mexican American Women With Prediabetes NCT02488057	Completed	P4	Ohio State University
Cardiovascular Effects of GLP-1 Receptor Activation NCT03101930	Completed	P4	Vanderbilt University Medical Center
RISE Adult Medication Study NCT01779362	Completed	P3	RISE Study Group
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM) NCT01234649	Completed	P3	Woman's
Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients? NCT01845259	Unknown	P2	Psychiatric Centre Rigshospitalet
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans NCT02403284	Completed	P4	Phoenix VA Health Care System
Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS NCT03480022	Completed	P3	Woman's
Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD. NCT01784965	Completed	P3	Stanford University
The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure NCT02284230	Withdrawn	P2	Bo Feldt-Rasmussen
Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study NCT02472717	Withdrawn	P2	University Health Network, Toronto

See the full record for liraglutide, or every molecule being studied in prediabetes. These are registered trials, nothing more. Most drugs tested in a new condition never get approved for it, and plenty of these will report nothing useful.